Genzyme, Valeant Pharmaceuticals sales and marketing update

Genzyme granted Valeant's Biovail Laboratories International SRL subsidiary rights to market Cholestagel colesevalem in Canada. The non-absorbed bile acid sequestrant is approved to treat hypercholes...